|
Autor/a:
|
Farré, Núria; Vela-Vallespín, Emili; Clèries, Montse; Bustins, Montse; Cainzos-Achirica, Miguel; Enjuanes, Cristina; Moliner, Pedro; Ruiz, Sonia; Verdú Rotellar, José María; Comin-Colet, Josep
|
|
Otros autores:
|
[Farré N, Enjuanes C, Moliner P] Programa d'Insuficiència Cardíaca. Departament de Cardiologia, Hospital del Mar, Barcelona, Spain. Grup de recerca biomédica en malalties del cor, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. [Vela E, Clèries M, Bustins M] Divisió d'Anàlisi de la Demanda i l'Activitat, Servei Català de la Salut, Barcelona, Spain. [Cainzos-Achirica M] Ciccarone Center for the Prevention of Heart Disease, Department of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America. Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, United States of America. [Ruiz S] Programa d'Insuficiència Cardíaca. Departament de Cardiologia, Hospital del Mar, Barcelona, Spain. Grup de recerca biomédica en malalties del cor, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. [Verdú-Rotellar JM] Grup de recerca biomédica en malalties del cor, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. [Comín-Colet J] Grup de recerca biomédica en malalties del cor, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. Grup d’Insuficiència cardíaca, Departament de Cardiologia, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain. Facultat de Medicina i Ciències de la Salut, Departament de Ciències Clíniques, Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain; IDIAP Jordi Gol |
|
Abstract:
|
BACKGROUND Heart failure (HF) is frequent and its prevalence is increasing. We aimed to evaluate the epidemiologic features of HF patients, the 1-year follow-up outcomes and the independent predictors of those outcomes at a population level. METHODS AND RESULTS Population-based longitudinal study including all prevalent HF cases in Catalonia (Spain) on December 31st, 2012. Patients were divided in 3 groups: patients without a previous HF hospitalization, patients with a remote (>1 year) HF hospitalization and patients with a recent (<1 year) HF admission. We analyzed 1year all-cause and HF hospitalizations, and all-cause mortality. Logistic regression was used to identify the independent predictors of each of those outcomes. A total of 88,195 patients were included. Mean age was 77 years, 55% were women. Comorbidities were frequent. Fourteen percent of patients had never been hospitalized, 71% had a remote HF hospitalization and 15% a recent hospitalization. At 1-year follow-up, all-cause and HF hospitalization were 53% and 8.8%, respectively. One-year all-cause mortality rate was 14%, and was higher in patients with a recent HF hospitalization (24%). The presence of diabetes mellitus, atrial fibrillation or chronic kidney disease was independently associated with all-cause and HF hospitalization and all-cause mortality. Hospital admissions and emergency department visits the previous year were also found to be independently associated with the three study outcomes. CONCLUSIONS Outcomes are different depending on the HF population studied. Some comorbidity, an all-cause hospitalization or emergency department visit the previous year were associated with a worse outcome. |
